WO2004058807A3 - Mhc class i restricted t-cell stimulating peptides from hepatitis b virus - Google Patents
Mhc class i restricted t-cell stimulating peptides from hepatitis b virus Download PDFInfo
- Publication number
- WO2004058807A3 WO2004058807A3 PCT/EP2003/013948 EP0313948W WO2004058807A3 WO 2004058807 A3 WO2004058807 A3 WO 2004058807A3 EP 0313948 W EP0313948 W EP 0313948W WO 2004058807 A3 WO2004058807 A3 WO 2004058807A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- hepatitis
- virus
- restricted
- mhc class
- cell stimulating
- Prior art date
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 241000700721 Hepatitis B virus Species 0.000 title 1
- 230000004936 stimulating effect Effects 0.000 title 1
- 238000000034 method Methods 0.000 abstract 2
- 238000003745 diagnosis Methods 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003293807A AU2003293807A1 (en) | 2002-12-24 | 2003-12-09 | Mhc class i restricted t-cell stimulating peptides from hepatitis b virus |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02447276.3 | 2002-12-24 | ||
EP02447276 | 2002-12-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2004058807A2 WO2004058807A2 (en) | 2004-07-15 |
WO2004058807A3 true WO2004058807A3 (en) | 2004-09-30 |
Family
ID=32668936
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2003/013948 WO2004058807A2 (en) | 2002-12-24 | 2003-12-09 | Mhc class i restricted t-cell stimulating peptides from hepatitis b virus |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003293807A1 (en) |
WO (1) | WO2004058807A2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102796172B (en) * | 2011-05-23 | 2015-03-25 | 中国科学院微生物研究所 | Hepatitis B virus (HBV) specific human leukocyte antigen-A33 (HLA-A33) restrictive epitope peptides and application thereof |
JP7017012B2 (en) | 2018-05-09 | 2022-02-08 | ソウル大学校産学協力団 | Hepatitis B virus-derived polypeptide and its antiviral use |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2926641A1 (en) * | 2013-10-11 | 2015-04-16 | Tarix Pharmaceuticals Ltd. | Novel peptide compositions |
US9133241B2 (en) | 2013-10-11 | 2015-09-15 | Tarix Pharmaceuticals Ltd. | Peptide compositions |
WO2015130488A2 (en) * | 2014-02-28 | 2015-09-03 | Immunotope, Inc. | Mhc class i associated peptides for prevention and treatment of hepatitis b virus infection |
EP3181146A1 (en) * | 2015-12-16 | 2017-06-21 | Ruprecht-Karls-Universität Heidelberg | Cyclic ntcp-targeting peptides and their uses as entry inhibitors |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994020127A1 (en) * | 1993-03-05 | 1994-09-15 | Cytel Corporation | Hla-a2.1 binding peptides and their uses |
US5932224A (en) * | 1991-08-26 | 1999-08-03 | The Scripps Research Institute | Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus |
US6117653A (en) * | 1987-06-22 | 2000-09-12 | Medeva Holdings B.V. | Hepatitis B surface antigen vaccine |
WO2002019986A1 (en) * | 2000-09-08 | 2002-03-14 | Epimmune Inc. | Inducing cellular immune responses to hepatitis b virus using peptide and nucleic acid compositions |
-
2003
- 2003-12-09 AU AU2003293807A patent/AU2003293807A1/en not_active Abandoned
- 2003-12-09 WO PCT/EP2003/013948 patent/WO2004058807A2/en not_active Application Discontinuation
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6117653A (en) * | 1987-06-22 | 2000-09-12 | Medeva Holdings B.V. | Hepatitis B surface antigen vaccine |
US5932224A (en) * | 1991-08-26 | 1999-08-03 | The Scripps Research Institute | Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus |
WO1994020127A1 (en) * | 1993-03-05 | 1994-09-15 | Cytel Corporation | Hla-a2.1 binding peptides and their uses |
WO2002019986A1 (en) * | 2000-09-08 | 2002-03-14 | Epimmune Inc. | Inducing cellular immune responses to hepatitis b virus using peptide and nucleic acid compositions |
Non-Patent Citations (3)
Title |
---|
LOGEAN A ET AL: "RECOVERY OF KNOW T-CELL EPITOPES BY COMPUTATIONAL SCANNING OF A VIRAL GENOME", JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, ESCOM SCIENCE PUBLISHERS BV, XX, vol. 16, no. 4, April 2002 (2002-04-01), pages 229 - 243, XP009008301, ISSN: 0920-654X * |
NAYERSINA R ET AL: "HLA A2 RESTRICTED CYTOTOXIC T LYMPHOCYTE RESPONSES TO MULTIPLE HEPATITIS B SURFACE ANTIGEN EPITOPES DURING HEPATITIS B VIRUS INFECTION", JOURNAL OF IMMUNOLOGY, THE WILLIAMS AND WILKINS CO. BALTIMORE, US, vol. 150, no. 10, 15 May 1993 (1993-05-15), pages 4659 - 4671, XP000609159, ISSN: 0022-1767 * |
TAN WEN SIANG: "Inhibition of hepatitis B virus assembly with synthetic peptides derived from the viral surface and core antigens", JOURNAL OF GENERAL AND APPLIED MICROBIOLOGY, vol. 48, no. 2, April 2002 (2002-04-01), pages 103 - 107, XP009031079, ISSN: 0022-1260 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102796172B (en) * | 2011-05-23 | 2015-03-25 | 中国科学院微生物研究所 | Hepatitis B virus (HBV) specific human leukocyte antigen-A33 (HLA-A33) restrictive epitope peptides and application thereof |
JP7017012B2 (en) | 2018-05-09 | 2022-02-08 | ソウル大学校産学協力団 | Hepatitis B virus-derived polypeptide and its antiviral use |
Also Published As
Publication number | Publication date |
---|---|
WO2004058807A2 (en) | 2004-07-15 |
AU2003293807A1 (en) | 2004-07-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005118626A3 (en) | Peptides for inducing a ctl and/or htl response to hepatitis c virus | |
EP1594536A4 (en) | Adjuvanted influenza vaccine | |
EP1200109A4 (en) | Inducing cellular immune responses to hepatitis c virus using peptide and nucleic acid compositions | |
SG156652A1 (en) | Yeast-based therapeutic for chronic hepatitis c infection | |
MX342639B (en) | High titer recombinant influenza viruses for vaccines and gene therapy. | |
IL205958A0 (en) | Immunogenic composition and method of developing a vaccine based on portions of the hiv matrix protein | |
WO2006086188A3 (en) | Use of consensus sequence as vaccine antigen to enhance recognition of virulent viral variants | |
WO2007008918A3 (en) | Virus vaccines comprising envelope-bound immunomodulatory proteins and methods of use thereof | |
FR2827605B1 (en) | NOVEL PEPTIDES DERIVED FROM RSV PROTEIN G AND THEIR USE IN A VACCINE | |
HK1047892A1 (en) | Hcv vaccine compositions | |
TW200502246A (en) | Vaccine | |
WO2007046839A3 (en) | New live virus vaccines | |
WO2005058349A3 (en) | Vaccine comprising il-12 or il-23 for treatment of autoimmune diseases | |
WO2000012535A3 (en) | Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof | |
WO2003011331A3 (en) | Materials and methods relating to improved vaccination strategies | |
GB2429711A (en) | Heart and skeletal muscle inflammation (HSMI) virus | |
WO2004058807A3 (en) | Mhc class i restricted t-cell stimulating peptides from hepatitis b virus | |
WO2007121491A8 (en) | Hcv vaccinations | |
WO2006024240A3 (en) | Vaccine composition against hepatitis c virus | |
WO2005011571A3 (en) | Hepatitis virus core proteins as vaccine platforms and methods of use thereof | |
WO2007020520A3 (en) | Antigenic peptides and their use | |
WO2000052045A3 (en) | Mage-3 derived immunogenic peptides presented by mhc of class ii and the use thereof | |
WO2006110881A3 (en) | Yersinia polypeptide vaccines, antibodies and immunomodulatory proteins | |
WO2004092386A3 (en) | Inducing a t cell response with recombinant pestivirus replicons or recombinant pestivirus replicon-transfected dendritic cells | |
IL149415A0 (en) | Adjuvanted genetic vaccines |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |